BR112018076512A2 - método para gerenciar eventos adversos em populações de pacientes que requerem transfusão - Google Patents

método para gerenciar eventos adversos em populações de pacientes que requerem transfusão

Info

Publication number
BR112018076512A2
BR112018076512A2 BR112018076512-0A BR112018076512A BR112018076512A2 BR 112018076512 A2 BR112018076512 A2 BR 112018076512A2 BR 112018076512 A BR112018076512 A BR 112018076512A BR 112018076512 A2 BR112018076512 A2 BR 112018076512A2
Authority
BR
Brazil
Prior art keywords
adverse events
patient populations
requiring transfusion
transfusion
managing adverse
Prior art date
Application number
BR112018076512-0A
Other languages
English (en)
Inventor
D'alessandro Angelo
Cordero Rafael
Dunham Andrew
Keegan Philip
Yoshida Tatsuro
Original Assignee
New Health Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Health Sciences, Inc. filed Critical New Health Sciences, Inc.
Publication of BR112018076512A2 publication Critical patent/BR112018076512A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0272—Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)

Abstract

a presente invenção trata de um método para medicina de transfusão para reduzir eventos adversos em populações de pacientes de transfusão com base em fisiologia de paciente subjacente.
BR112018076512-0A 2016-06-23 2017-06-22 método para gerenciar eventos adversos em populações de pacientes que requerem transfusão BR112018076512A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662354041P 2016-06-23 2016-06-23
US62/354,041 2016-06-23
PCT/US2017/038859 WO2017223377A1 (en) 2016-06-23 2017-06-22 Methods for managing adverse events in patient populations requiring transfusion

Publications (1)

Publication Number Publication Date
BR112018076512A2 true BR112018076512A2 (pt) 2019-04-02

Family

ID=59337864

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018076512-0A BR112018076512A2 (pt) 2016-06-23 2017-06-22 método para gerenciar eventos adversos em populações de pacientes que requerem transfusão

Country Status (10)

Country Link
US (3) US20190388467A1 (pt)
EP (2) EP3474922A1 (pt)
JP (2) JP7053508B2 (pt)
CN (2) CN115429961A (pt)
AU (2) AU2017281514B2 (pt)
BR (1) BR112018076512A2 (pt)
CA (1) CA3028435A1 (pt)
IL (3) IL297507B2 (pt)
MX (1) MX2018016103A (pt)
WO (1) WO2017223377A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017223377A1 (en) * 2016-06-23 2017-12-28 New Health Sciences, Inc. Methods for managing adverse events in patient populations requiring transfusion
PT3624812T (pt) * 2017-05-19 2022-11-30 Hemanext Inc Métodos e tratamento de trauma
CN113365642A (zh) * 2018-11-16 2021-09-07 希玛奈克斯特股份有限公司 用于控制炎症患者中不良事件的方法
WO2024086835A1 (en) * 2022-10-20 2024-04-25 Hemanext Inc. Treatment of blood transfusion-dependent patients with hematologic malignancies
WO2024086834A1 (en) * 2022-10-20 2024-04-25 Hemanext Inc. Treatment of burn patients with hypoxic blood

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6447987B1 (en) 1978-09-09 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Prolonged storage of red blood cells
US4769318A (en) 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US4880786A (en) 1987-01-14 1989-11-14 Ube Industries, Ltd. Additive solution for blood preservation and activation
US5120659A (en) 1989-06-26 1992-06-09 Mine Safety Appliances Company Deuterated water test method
US5789152A (en) 1991-04-30 1998-08-04 Basil T. Hone Composition and method for detecting HIV with baculovirus derived vesicles
US5476764A (en) 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US5624794A (en) 1995-06-05 1997-04-29 The Regents Of The University Of California Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas
US6162396A (en) 1997-04-26 2000-12-19 The Regents Of The University Of California Blood storage device and method for oxygen removal
US5789151A (en) 1997-05-15 1998-08-04 The Regents Of The University Of California Prolonged cold storage of red blood cells by oxygen removal and additive usage
US20020159995A1 (en) * 1997-07-30 2002-10-31 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
US6413713B1 (en) 1998-10-30 2002-07-02 Hyperbaric Systems Method for preserving blood platelets
US20030124504A1 (en) 2001-11-16 2003-07-03 Bitensky Mark W. Additive solution for blood preservation
CA2789592C (en) * 2007-08-31 2015-05-12 The Regents Of The University Of Michigan Selective cytopheresis devices and related methods thereof
US8430831B2 (en) * 2009-02-25 2013-04-30 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
WO2010147621A1 (en) * 2009-06-16 2010-12-23 The Trustees Of Columbia University In The City Of New York Methods for ameliorating adverse effects associated with transfusion of aged red blood cells
US9199016B2 (en) * 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
JP6199557B2 (ja) * 2009-10-12 2017-09-20 ニュー ヘルス サイエンシーズ、インク．Ｎｅｗ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 酸素及び二酸化炭素の減損能力をもつ血液保存袋システム及び減損装置
CA2782311C (en) * 2009-12-01 2017-06-27 Robert S. Ward Method for removing cytokines from blood with surface immobilized polysaccharides
EP2729000B1 (en) * 2011-07-05 2022-12-14 Hemanext Inc. A method for extended storage of red blood cells
BR122021024410B1 (pt) * 2015-05-18 2022-05-03 Hemanext Inc Métodos para gerenciar um banco de sangue e para prover fornecimento de produtos de sangue total armazenados para medicina de transfusão
WO2017223377A1 (en) * 2016-06-23 2017-12-28 New Health Sciences, Inc. Methods for managing adverse events in patient populations requiring transfusion

Also Published As

Publication number Publication date
AU2017281514A1 (en) 2019-01-17
CN109414542A (zh) 2019-03-01
IL263695B2 (en) 2023-03-01
CN115429961A (zh) 2022-12-06
IL297507B1 (en) 2023-09-01
IL263695A (en) 2019-02-28
US11090331B2 (en) 2021-08-17
IL297507A (en) 2022-12-01
JP7267482B2 (ja) 2023-05-01
JP2019521998A (ja) 2019-08-08
AU2017281514B2 (en) 2022-11-24
MX2018016103A (es) 2019-05-02
EP3474922A1 (en) 2019-05-01
AU2022259846A1 (en) 2022-12-08
JP7053508B2 (ja) 2022-04-12
US20230047634A1 (en) 2023-02-16
IL297507B2 (en) 2024-01-01
US20190388467A1 (en) 2019-12-26
IL263695B (en) 2022-11-01
EP4321215A3 (en) 2024-04-17
US20200276234A1 (en) 2020-09-03
CN109414542B (zh) 2022-09-09
JP2022093350A (ja) 2022-06-23
EP4321215A2 (en) 2024-02-14
CA3028435A1 (en) 2017-12-28
IL305115A (en) 2023-10-01
WO2017223377A1 (en) 2017-12-28

Similar Documents

Publication Publication Date Title
BR112018076512A2 (pt) método para gerenciar eventos adversos em populações de pacientes que requerem transfusão
CU20170172A7 (es) 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos
BR112019021914A2 (pt) Combinação que compreende um agonista de ppar como elafibranor e um inibidor de acetil-coa carboxilase (acc)
BR112016000903A2 (pt) anticorpos
BR112018070199A2 (pt) composição farmacêutica de hormônio esteroide
BR112017016952A2 (pt) terapia de combinação com fatores de coagulação e anticorpos multiespecíficos
BR112016005816A2 (pt) Combinação de anticorpos anti-lag-3 e anticorpos anti-pd-1 para tratar tumores
WO2014134374A3 (en) Systems and methods for improving clinical documentation
EA201500934A1 (ru) Кардио- и нефропротективная противодиабетическая терапия
BR112018003184A2 (pt) absorvente feminino com braçadeiras de barreira
MX2015003143A (es) Gestion de datos microsismicos para equiparacion de fracturas.
BR112016013485A2 (pt) Método para preparar um produto lácteo tendo teor estável de galacto-oligossacarídeo(s)
BR112017004054A2 (pt) sistemas e métodos para fornecer funcionalidade com base em orientação de dispositivo
TWD222134S (zh) 病患連接裝置
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
WO2014210077A3 (en) Systems and methods for establishing and updating clinical care pathways
MX2016004097A (es) Metodos, dispositivos y sistemas para manejar datos de calendario.
BR112015014278A2 (pt) sistemas e métodos de colocação de lote
BR112018000187A2 (pt) composto, composição, método, e, uso de um composto ou composição
GB2524695A (en) Systems and methods for developing and managing oncology treatment plans
CO7350640A2 (es) Compuestos diméricos
UY35993A (es) Prolinas / piperidinas sustituidas como antagonistas del receptor de orexina
BR112013029026A2 (pt) filtro para artigos de fumo, arranjo de membros contendo aditivos de artigos de fumo e haste de filtro
UY35463A (es) Formulaciones de polipéptido fc-factor ix.
BR112017018726A2 (pt) ?método implementado por computador para associar um usuário a um dispositivo vestível, e, sistema para associar um usuário a um dispositivo vestível?.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: HEMANEXT INC. (US)

B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61M 1/36 , A61M 1/38 , A61K 35/14 , A61P 7/08

Ipc: A61K 35/14 (2015.01), A61M 1/38 (2006.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]